Leanne B. Gasink, MD

Spero Therapeutics Inc., Cambridge, MA, USA
Cambridge, Massachusetts, United States

Disclosure information not submitted.

Presentation(s):

• 173 - Oral Tebipenem Pivoxil Hydrobromide versus Intravenous Imipenem-Cilastatin in Patients with Complicated Urinary Tract Infections or Acute Pyelonephritis: Efficacy and Safety Results from the Phase 3 PIVOT-PO study

  Monday, October 20, 2025
  2:09 PM - 2:21 PM US ET